Notably, RNF168 expression levels correlated with clinicopathological features of the tumor, such as pathological staging and depth of invasion (Table 1), indicating that RNF168 may serve as a biomarker of malignancy in ESCC. The gene discussed is RNF168; the disease is esophageal squamous cell carcinoma.